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Introduction
Bacterial infections are increasingly prevalent due to rapid 
changes in the patient population and increased number 
of  chronic diseases and immunosuppressed patients. The 
increase in antibiotic resistance complicates the treatment of  
Pseudomonas aeruginosa (P. aeruginosa), coagulase-negative 
Staphylococcus (CNS) and especially S. aureus infections1.
S. aureus is a pathogen that can cause invasive infections such 
as endocarditis, osteomyelitis and sepsis as well as skin and 
soft tissue infections that can be colonized in humans and 
animals2. Although the pathogenicity of  CNS is lower than 
that of  S. aureus, it has been observed to be more frequently 
isolated in invasive infections in recent years. In the United 
States, 80.461 invasive methicillin-resistant S. aureus (MRSA) 
infections were reported in 2011, of  which 11.285 resulted 
in death. In the same study, it was found that approximately 
51.000 hospital-acquired P.aeruginosa infections occurred, 
of  which 13% were due to multi drug resistance (MDR) P. 
aeruginosa and 400 resulted in death. Along with a reduction 
in the number of  antibiotics that can be used in the treatment 
of  infections, infections that cannot be controlled indicate a 
universal danger3.
A toxin-antitoxin (TA) system is a set of  two or more 
closely linked genes that are encoded as a poison and a 
corresponding antidote on a protein. In typical bacterial 
physiology, an antitoxin binds to a toxin and neutralizes it, 
which prevents the bacterium from killing itself. When the 
antitoxin is degraded or not functional, the toxin kills the 
bacterium; this is known as a programmed cell death4.
TA systems are genes encoded on chromosomes and 
plasmids5 that can be found in both Gram-negative and 
Gram-positive bacteria6. Studies over the past 30 years 
have revealed detailed information about the functions and 
movement mechanisms of  TA systems as well as various 
interesting results regarding the importance of  such systems 
for bacterial physiology7,8.
Generally, toxin molecules act as negative regulators for cell 
life, whereas antitoxin molecules act as positive regulators. 
The interaction between toxin and antitoxin gene expression 
levels in stressful conditions is vital for the life of  the bacteria. 
Therefore, studies are being conducted on the possibility 
that TA systems can be used to develop new antibiotics9-11.
Bacteria often have more than one TA system in their 
genome12. The presence and type of  TA systems and whether 
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A toxin-antitoxin (TA) system is a set of  two or more closely linked genes that are encoded as a poison and a corresponding antidote on 
a protein. In typical bacterial physiology, an antitoxin binds to a toxin and neutralizes it, which prevents the bacterium from killing itself. 
We aimed to determine whether P.aeruginosa and Staphylococcus isolates have TA genes and to investigate whether there is a relationship 
between the expression levels of  TA genes and resistance to antibiotics.
Methods
This study included 92 P. aeruginosa and 148 Staphylococcus isolates. RelBE, higBA genes were investigated in P.aeruginosa by multiplex 
polymerase chain reaction (PCR).  The mazEF gene and the all TA genes expression were detected by real time PCR. 
Results
RelBE and higBA genes were detected in 100% of P. aeruginosa. It was found that the level of  relBE TA gene expression is increased 
in isolates sensitive to aztreonam compared to resistant isolates (p<0.05).The mazEF gene was detected in 89.1% of  Staphylococcus 
isolates. In terms of  MazEF gene expression level there was no significant difference between methicillin-sensitive Staphylococcus aureus 
(MSSA) and methicillin-resistant S. aureus (MRSA) isolates (p>0.05) whereas there was a significant difference between MSSA and 
coagulase-negative Staphylococcus (CNS) isolates, MRSA and CNS isolates (p<0.05). The levels of  mazEF gene expression were found 
to be higher in isolates sensitive to gentamicin, ciprofloxacin, levofloxacin, clindamycin, phosphomycine, nitrofurantoin, fusidic acid, 
cefoxitin compared to resistant isolates (p<0.05). 
Conclusion
Studies on the prevalence and functionality of  TA systems emphasize that it may be possible to have new sensitive regions in bacteria 
by activating TA systems. The results of  this study lead to the idea that resistance to antibiotics can be reduced by increasing TA gene 
expression levels. But there is need for further studies to support and develop this issue.
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primer binding at 52°C for 45 seconds, and for the MazEF 
primer binding at 54°C for 30 seconds and then elongation 
at 72°C for 30 seconds, followed by a final elongation step by 
increasing from 60°C to 90°C.
Statistical Method
In study, Shapiro-Wilk’s test was used to assess the data 
normality. When the data of  the Staphylococcus isolates were 
evaluated, independent samples t test was used to compare 
the normally distributed independent variables between two 
groups and Mann-Whitney U test was used to compare the 
non normally distributed independent variables between two 
groups. One-way ANOVA test was used in three groups 
comparisons. For multiple comparisons, the Tukey HSD test 
was used. The difference between resistance to antibiotics 
in P. aeruginosa isolates and transcription levels of  TA genes 
was investigated with an independent samples t-test. The 
statistical significance level of  p was 0.05. Statistical analysis 
was performed using commercial software (IBM SPSS 
Statistics 20, SPSS Inc., an IBM Co., Somers, NY).
Results
P. aeruginosa and isolates were identified in respiratory tract 
specimens (36 endotracheal aspirates and 9 bronchoalveolar 
lavages) at a rate of  46.7%, whereas Staphylococcus isolates 
were most frequently identified in blood culture samples 
at a rate of  58.8%. The sample types in which the isolates 
were identified are shown in Table 2. In the P. aeruginosa 
isolates, aztreonam was identified as the most sensitive 
antibiotic type, whereas the highest resistance rates were 
detected against carbapenems, at a rate of  67% and 59.8% 
for meropenem and imipenem, respectively. The antibiotics 
Total RNA isolation from P. aeruginosa and 
Staphylococcus isolates 
The prepared 30± 5 ng/ µL bacterial suspension was 
centrifuged at 12.500 xg for 5 minutes. Then 200 μL of  
RB buffer (RB buffer, β-Mercaptoethanol) was added to 
the pellet and RNA isolation was performed according to 
the supplier’s recommendation. In addition, 20 μL of  10X 
Reaction mix, 7.5 μL of  DNase I and 172.5 μL of  water 
were added for degradation of  the genomic DNA during the 
protocol and pure RNA was obtained. 
Table 2: Distribution of clinical specimens of P. 




Sample type n / % n / %
Endotracheal 
aspirate
34 / 37 4 / 8.3
Blood 23 / 25 87 / 58.8
Wound 10 / 10.8 24 / 16.2
Bronchoalveolar 
lavage 9 / 9.7 -
Pleural effusion 5 / 5.4 -
Catheter 4 / 4.3 1 / 0.7
Urine 3 / 3.3 6 / 4
Abscess 3 / 3,3 3 / 2
Tissue 1 / 1.1 -
Joint fluid - 1 / 0.7
Conjunctiva - 1 / 0.7
Cerebrosp ina l 
fluid - 6 / 4
Sputum - 15 / 10.1
Preparation of cDNA from total RNA in P. 
aeruginosa and Staphylococcus isolates: 
The cDNA was prepared by adding 10 μL of  water, 8 μL 
of  reaction mix and 2 μL of  reverse transcriptase (RT), to a 
final volume of  20 μL. The cDNA was prepared for a total 
of  40 minutes with the amplification steps of  5 minutes at 
22°C, 30 minutes at 42°C, 5 minutes at 85°C. The identity of  
the cell number of  the resulting cDNAs was confirmed by 
measuring with NanoDrop spectrophotometer. The activity 
of  the gene region was proven by the detection of  the cDNA 
using SYBR green dye.
Detection of TA gene expression in P. aeruginosa 
and Staphylococcus isolates by real time PCR 
The mazEF and relBE genes were prepared by adding 12.5 
μL of  Super SYBR Mix and for the relBE and higBA genes, 
0.5 μL (+) and (-) of  primer and for the mazEF gene, 0.25 
μL (+) and (-) of  primer, 6.5 μL of  water, and 3 μL of  
cDNA, to obtain a total of  20 μL mix. The amplification 
program included 3 minutes of  denaturation at 95°C and 
45 cycles of  15 seconds denaturation at 95°C for the RelBE 
primer binding at 56°C for 45 seconds, for the HigBA 
they are encoded on a plasmid or on a chromosome varies 
between bacteria9.
To our knowledge, there is no study showing the existence 
of  TA systems in methicillin-sensitive Staphylococcus aureus 
(MSSA) and CNS isolates. The aim of  this study was 
to determine whether P.aeruginosa isolates isolated from 
clinical specimens have relBE 
and higBA TA systems and 
whether Staphylococcus isolates 
have mazEF TA systems, and 
to investigate whether there 
is a relationship between the 
expression levels of  TA genes 
and resistance to antibiotics.
Methods
Ethical Information
This study was approved 
by the Scientific and 
Ethical Committee of  the 
Gaziosmanpasa University 
Clinical Research Ethics 
Committee (Tokat, Turkey), 
(16-KAEK-061/03.03.2016).
Bacterial strains and antimicrobial susceptibility 
testing
This study included 92 P. aeruginosa isolates from various 
specimens sent to the Microbiology Laboratory at Recep 
Tayyip Erdogan University Training and Research Hospital 
between December 2013 and March 2015 and a total of  148 
Staphylococcus isolates (58 MRSA, 49 MSSA and 41 CNS), 
isolated from various clinical samples sent to the Microbiology 
Laboratory at Gaziosmanpasa University between January 
and August 2016 as well as to the Microbiology Laboratory 
at Amasya Training and Research Hospital between January 
2015 and August 2016. 
For the identification and antimicrobial susceptibility, 
tests were performed in accordance with the CLSI 
recommendations using the Vitek-2 (BioMérieux) or the BD 
Phoenix automated microbiology system (Becton Dickinson 
Diagnostic Systems, Sparks, Md.)13. The susceptibility of  P. 
aeruginosa isolates to meropenem, imipenem, cefoperazone-
sulbactam, ceftazidime, piperacillin-tazobactam, 
ciprofloxacin, cefepime, aztreonam and the susceptibility 
of  Staphylococcal isolates to penicillin, cefoxitin, gentamicin, 
erythromycin, clindamycin, linezolid, daptomycin, teicoplanin, 
vancomycin, ciprofloxacin, levofloxacin, tetracycline, fusidic 
acid, and trimethoprim-sulfamethoxazole were investigated. 
Isolates with moderate sensitivity were considered resistant. 
P. aeruginosa ATCC 27853 and S. aureus ATCC 25923 were 
used as quality control strains. Stock cultures were stored at 
-80ºC in Luria Broth (LB)14 or bead stock medium. 
Genomic isolation of relBE and higBA genes from 
P. aeruginosa isolates by multiplex PCR
RelBE, higBA genes were investigated in P.aeruginosa strains 
by multiplex polymerase chain reaction (PCR). A total of  1.5 
ml (30± 5 ng/ µL) of  bacterial cultures prepared for mold 
DNA isolation was placed into a 1.5 mL microcentrifuge 
tube and precipitated for 5 minutes at 13.000 xg. The upper 
part of  the centrifuged liquid was discarded and washed 
with sterile distilled water. PCRs were performed on a final 
volume of  50 µL and included 5 μL of  genomic DNA, 20 
pM of  each primer, 10 μL reaction buffer (Promega), 3 μL 
25 mM MgCl2, 200 μM of  each dNTP and 1.5 U of  Taq 
Polymerase (Promega, USA). PCR amplification conditions 
were as follows: initial denaturation at 94°C for 3 minutes 
followed by 30 cycles of  25 seconds at 94°C, 40 seconds 
at 52°C and 50 seconds at 72 °C with a final extension of  
5 minutes at 72°C. All PCR results were analyzed on 1% 
agarose containing 0.5 μg/mL ethidium bromide and were 
subsequently visualized under UV light. The primers used 
in multiplex PCR and real-time PCR are shown in (Table 1). 
The gel images of  relBE and higBA TA genes are given in 
(Figure 1).
Figure 1: Multiplex PCR images of P. aeruginosa 
relBE and higBa TA genes
Genomic DNA isolation of mazEF gene from 
Staphylococcus isolates by real-time PCR 
The prepared 30± 5 ng/ µL bacterial suspension was 
centrifuged at 12.500 xg for 5 minutes. Then, 200 μL of  
lysozyme was added onto the pellet and incubated at 37ºC 
for 30 minutes. For the degradation of  RNA, 4 μL RNase 
A (50mg/ml) was added to the sample and was vortexed for 
10 minutes at room temperature. Then 40 μL proteinase K 
was added and the DNA isolation was completed according 
to the supplier’s recommendation (Anatolia Geneworks 
Turkey).
Table 1: Primers used for detection of TA genes and analysis of real time PCR 
in P. aeruginosa and Staphylococus clinical isolates.
Primer name          5’-3’ Sequence                Expected Fragment, bp    Application Reference
mazEF
F- 











CTCATGTTCGATCTGCTTGC                              
469 18
Table 3: Antibiotic resistance rates of P. aeruginosa and 
Staphylococcus isolates.
P. aeruginosa Staphylococcus isolates
Antibiotic n / % Antibiotic n / % 
Meropenem 59 / 67 Penicillin 126 / 95.5
Imipenem 52 / 59.8 Sefoksitin 84 / 63.6
Cefoperazone-
sulbactam 36 / 42.9 Gentamicin 36 / 27.3
Ceftazidime 20 / 23.8 Erythromycin 101 / 7.6
P ipe rac i l l i n -
tazobactam 19 / 21.8 Clindamycin 41 / 31
Ciprofloxacin 19 / 21.8 Linezolid 0
Cefepime 14 / 15.9 Daptomycin 0






T r i m e t h o p r i m -
sulfamethoxazole 22/16.6
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most resistant against Staphylococcus isolates were penicillin 
(95.5%) and erythromycin (76.5%). Resistance rates against 
antibiotics are shown in Table 3. HigBA and relBE genes 
were detected in 100% of  the isolates (n=92). For each 
screened gene, the sample was displayed by running on the 
agarose gel (Figure 1). The mazEF gene was detected in 132 
(89.1%) of  148 Staphylococcus isolates. The resistance rates of  
isolates to antibiotics and the average cycle threshold (Ct) 
values for the mazEF gene are shown in Table 4. The mean 
Ct values were 23.9 ± 8.8 for the relBE gene and 18.24 ± 
5.8 for the higBA gene. The RelBE TA gene expression level 
was found to be increased in isolates sensitive to aztreonam 
compared to resistant isolates (p<0.05). The distribution 
of  MazEF values by groups is shown in Figure 2. In terms 
of  MazEF gene expression levels, there was no significant 
difference between MSSA and MRSA isolates (p=0.181), 
whereas there was significant difference between the MSSA 
and CNS isolates (p<0.001) and MRSA and CNS isolates 
(p<0.05). The levels of  mazEF gene expression were found 
to be higher in isolates sensitive to gentamicin, ciprofloxacin, 
levofloxacin, clindamycin, nitrofurantoin, fusidic acid and 
cefoxitin compared to resistant isolates (p<0.05). The level 
of  gene expression was found to be higher in isolates without 
inducible clindamycin-resistance compared to thoswith 
inducible clindamycin resistance (p<0.05).
Discussion
Bacteria often have more than one TA system in their 
genome12. The presence and type of  TA systems and 
whether they are encoded on a plasmid or on a chromosome 
varies between bacteria4.  TA systems are thought to be 
encoded on chromosomes in the P. aeruginosa15,16. Based on 
bioinformatic data, four TA systems were identified on P. 
aeruginosa, including PAQ1, relBE, higBA, and parDE17,18. 
However, a study by Gang Li et al. in 2016 identified a new 
TA gene named hibAB in the P. aeruginosa19. The studies 
have also revealed the existence of  new TA systems. The 
genes of  seven known TA gene families for S. aureus have 
been identified, with the majority of  the investigations 
involving the mazEF TA gene17,18. MazEF, an operon that 
is called a “plasmid addiction system” and which stabilizes 
plasmids, was first identified on the chromosome of  E. coli 
in 1993. MazEF is the most studied TA system in E. coli and 
has been reported to be an irreversible mediator in cell death 
in stress conditions20 as well as a modulator in the translation 
process21,22.
RelBE is also one of  the most studied TA systems in E. coli20. 
It modulates the response induced in the case of  amino acid 
starvation22, which leads to the inhibition of  translation and 
consequently to bacteriosis21. In the literature, E. coli appears 
to be the most frequently investigated bacterium for TA 
systems. HigBA was first described on Proteus vulgaris23. In a 
study conducted in the United States, it was reported that TA 
genes were encoded on the chromosome in P. aeruginosa and 
S. aureus isolated from clinical samples collected from three 
centers and that 100% of  the 78 MRSA isolates had higBA 
and relBE, whereas 30% had parDE and all 42 P. aeruginosa 
isolates had relBE and higBA TA genes. The authers of  the 
study confirmed the PCR products by DNA sequencing, 
with the result that 97.8% to 100% of  the PCR products 
were compatible with the DNA sequencing. In addition, they 
also emphasized that these genes are transcribed and that the 
activation of  toxin genes would be an effective antibacterial 
strategy15. In a study conducted in 2016, 174 P. aeruginosa 
isolates isolated from clinical specimens were found to have 
relBE, higBA and parDE TA genes at a rate of  100%, 100% 
and 30%, respectively in Iran16. Another study conducted in 
Iran by Hemati et al. showed that P. aeruginosa isolates had 
mazEF TA genes at a rate of  85.7% and that the isolates 
were resistant to gentamicin (65%), meropenem (60%), 
piperacillin (59.28%), and amikacin (52.14%). The authors 
found a correlation between mazEF genes and resistance 
to gentamicin, meropenem, piperacillin and amikacin24. In 
this study, higBA and relBE genes were found in all (100%) 
of  P. aeruginosa isolates, while the mazEF gene was found in 
89.1% of  the Staphylococcus isolates. The results of  the study 
are consistent with the literature and show that TA genes 
are present at high rates in P. aeruginosa and Staphylococcus 
isolates. In Staphylococcus isolates, the levels of  mazEF 
gene expression were found to be higher in isolates sensitive 
to gentamicin, ciprofloxacin, levofloxacin, clindamycin, 
phosphomycin, nitrofurantoin, fusidic acid and cefoxitin 
compared to resistant isolates (p<0.05). In P. aeruginosa 
isolates, in contrast to the study by Hemati et al.24, the relBE 
TA gene expression level was found to be increased in 
isolates sensitive to aztreonam compared to resistant isolates 
(p<0.05). For Staphylococcus isolates, the existence of  TA 
systems has been proven only in MRSA isolates, while these 
systems remained unexplored in CNS and MSSA isolates. 
In this study, we evaluated the presence of  TA systems 
in MSSA and CNS and observed the transcription of  the 
mazEF TA gene in MRSA and MSSA isolates is higher than 
in CNS (p<0.05). This suggests that the mazEF TA gene 
may be related to virulence in S. aureus. To our knowledge, 
this is the first study investigating TA genes in the CNS. 
The determination of  the prevalence of  TA genes in 
strains with less virulence will also contribute to the studies 
investigating the possibility that TA systems are antibacterial 
targets. Bukowski et al.25 suggests that TA systems induce 
bacteriosis, which in the long run result in the death of  
bacterial cells. The results of  Bukowski et al.25 and Hemati et 
al.24 also point out that drugs that can activate silent toxins in 
TA systems can be used as antibiotics. The present study is 
consistent with the results of  Bukowski et al.25 and Hemati et 
al.24 in terms of  the finding that isolates with higher mazEF 
gene expression levels were more sensitive to gentamicin, 
ciprofloxacin, levofloxacin, clindamycin, phosphomycin, 
nitrofurantoin, fusidic acid and cefoxitin. In the present 
study, the toxin and antitoxin genes were evaluated together 
because they were located on the same operon. Bacteria were 
not exposed to any stress factors, such as heat, amino acid 
starvation, or antibiotic exposure. We investigated only the 
presence of  these TA systems and the association between 
their presence and antibiotic resistance. Only the statistical 
determination of  these data constitutes a limitation of  this 
study. The studies on the prevalence and functionality of  
TA systems emphasizes that it may be possible to have new 
sensitive regions in bacteria by activating TA systems (by 
degrading antitoxins or increasing toxin expression)6,18. As 
a matter of  fact the results of  this study lead to the idea 
that resistance to antibiotics can be reduced by increasing TA 
gene expression levels. The most important step at this stage 
is to investigate the presence and functionality of  TA genes 
in microorganisms that cause infections. Therefore, there 
is require to investigate the presence and frequency of  TA 
genes in bacteria to support and develop this strategy and to 
determine which strategies are suitable for this target. Our 
study is the first study in Turkey investigating TA systems in 
P. aeruginosa and Staphylococcus isolates isolated from clinical 
specimens.
Conclusion
Studies on the prevalence and functionality of  TA systems 
emphasize that it may be possible to have new sensitive 
regions in bacteria by activating TA systems. The results of  
this study lead to the idea that resistance to antibiotics can be 
reduced by increasing TA gene expression levels. But there 
is need for further studies to support and develop this issue.
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